The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Marinelli, Sara ^a   Vacca, Valentina ^a   Ricordy, Ruggero ^a   Uggenti, Carolina ^b   Tata, Ada Maria ^b   Luvisetto, Siro ^a   Pavone, Flaminia ^a  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; CD11B ANTIGEN; COMPLEMENT RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; SODIUM CHLORIDE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ACETYLCHOLINE RELEASE; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TRANSPORT; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NERVE COMPRESSION; NERVE ENDING; NERVE REGENERATION; NERVOUS TISSUE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE; PROTEIN LOCALIZATION; SCHWANN CELL; SCIATIC NERVE INJURY; SINGLE DRUG DOSE; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

ACETYLCHOLINE; ANALGESICS; ANIMALS; ANTIGENS, CD11B; ASTROCYTES; BIOLOGICAL TRANSPORT; BOTULINUM TOXINS, TYPE A; CELL PROLIFERATION; CELLS, CULTURED; GANGLIA, SPINAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HINDLIMB; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROSCOPY, CONFOCAL; NERVE TISSUE PROTEINS; NEURALGIA; NEUROMUSCULAR AGENTS; NUCLEAR PROTEINS; PERIPHERAL NERVES; SCHWANN CELLS; SCIATIC NERVE; SPINAL CORD; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

ANIMALIA; MUS;

EID: 84868109504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047977     Document Type: Article

References (61)

1. Pavone F, Luvisetto S, (2010) Botulinum neurotoxin for pain management: insights form animal pain models. Toxins 2: 2890-2913.
2. Schiavo G, Matteoli M, Montecucco C, (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80: 717-766.
3. Schiavo G, Rossetto O, Catsicas S, Polverino de Laureto P, DasGupta BR, et al. (1993a) Identification of the nerve terminal targets of botulinum neurotoxin serotype A, D and E. J Biol Chem. 268: 32784-32787.
4. Rossetto O, Seveso M, Caccin P, Schiavo G, Montecucco C, (2001) Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon 39: 27-41.
5. Montecucco C, Rossetto O, Schiavo G, (2004) Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol 12: 442-446.
6. Schiavo G, Santucci A, DasGupta BR, Mehta PP, Jontes J, et al. (1993b) Botulinum neurotoxins serotype A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335: 99-103.
7. Montecucco C, Schiavo G, Pantano S, (2005) SNARE complexes and neuroexocytosis: how many, how close? Trends Biochem Sci 30: 367-372.
8. Megighian A, Scorzeto M, Zanini D, Pantano S, Rigoni M, et al. (2010) Arg206 of SNAP-25 is essential for neuroexocytosis at the Drosophila melanogaster neuromuscular junction. J Cell Sci 123: 3276-3283.
9. Montecucco C, Molgo J, (2005) Botulinal neurotoxins: revival of an old killer. Curr Op Pharmacol 5: 274-279.
10. Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M, (2008) Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci. 28: 3689-3696.
11. Caleo M, Antonucci F, Restani L, Mazzocchio R, (2009) A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism? J Neurochem 109: 15-24.
12. Bach-Rojecky L, Lacković Z, (2009) Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol Biochem Behav. 94: 234-238.
13. Bach-Rojecky L, Salković-Petrisić M, Lacković Z, (2010) Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection. Eur J Pharmacol 633: 10-14.
14. Matak I, Bach-Rojecky L, Filipovic B, Lackovic Z, (2011) Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience. 186: 201-207.
15. Matak I, Riederer P, Lackovic Z, (2012) Botulinum toxin's axonal transport from periphery to the spinal cord. Neurochem Int 61: 236-239.
16. Restani L, Antonucci F, Gianfranceschi L, Rossi C, Rossetto O, et al. (2011) Evidence for Anterograde Transport and Transcytosis of Botulinum Neurotoxin A (BoNT/A). J Neurosci 31: 15650-15659.
17. Restani L, Novelli E, Bottari D, Leone P, Barone I, et al. (2012) Botulinum neurotoxin A (BoNT/A) impairs neurotransmission following retrograde transynaptic transport. Traffic 13: 1083-1089.
18. Lawrence GW, Ovsepian SV, Wang J, Aoki KR, Dolly OJ, (2011) Extra-vesicular intra-neuronal migration of internalised botulinum neurotoxins without detectable inhibition of distal neurotrasmission. Biochem J 441: 443-452.
19. Currà A, Berardelli A, (2009) Do the unintended actions of botulinum toxin at distant sites have clinical implications? Neurology 72: 1095-1099.
20. Aoki KR, Francis J (2011) Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism Relat Disord (Suppl 1): S28-S33.
21. Luvisetto S, Marinelli S, Lucchetti F, Marchi F, Cobianchi S, et al. (2006) Botulinum neurotoxins and formalin-induced pain: central vs. Peripheral effects in mice. Brain Res 1082: 214-131.
22. Luvisetto S, Marinelli S, Cobianchi S, Pavone F, (2007) Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain. Neuroscience 145: 1-4.
23. Marinelli S, Luvisetto S, Cobianchi S, Makuch W, Obara I, et al. (2010) Botulinum neurotoxin type A counteracts neuropathic pain and facilitates fucntional recovery after peripheral nerve injury in animal models. Neuroscience 171: 316-328.
24. Mika J, Rojewska E, Makuch W, Korostynski M, Luvisetto S, et al. (2011) The effect of botulinum neurotoxin A on sciatic nerve injury-induced nuroimmunological changes in rat dorsal root ganglion and spinal cord. Neuroscience 175: 358-366.
25. Jessen KR, Morgan L, Stewart HJ, Mirsky R, (1990) Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions. Development 109: 91-103.
26. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM, (1991) Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 565: 1-7.
27. Hashizume H, De Leo JA, Colburn RW, Weinstein JN, (2000) Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 25: 1206-1217.
28. Pavone F, Marinelli S, Vacca V, Luvisetto S (2011) Is retrograde transport of boutlinum neurotoxin type A involved in its analgesic effects on neuropathic pain? 7th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Santa Fe, New Mexico, USA, October 2-5, 2011.
29. Loreti S, Ricordy R, De Stefano ME, Augusto-Tocco G, Tata MA, (2007) Acetylcholine inhibits cell cycle progression in rat Schwann cells by activation of the M2 receptor subtype. Neuron Glia Biol 3: 269-279.
30. Filipovic B, Matak I, Bach-Rojecky L, Lackovic Z, (2012) Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy. PloS ONE 7(1): e29803.
31. Salinas S, Bilsland LG, Schiavo G, (2008) Molecular landmarks along the axonal route: axonal transport in health and disease. Curr Op Cell Biol 20: 445-453.
32. Salinas S, Schiavo G, Kremer EJ, (2010) A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nature Rev Microbiol 8: 645-655.
33. Jessen KR, Mirsky R, (2005) The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 6: 671-682.
34. Triolo D, Dina G, Lorenzetti I, Malaguti M, Morana P, et al. (2006) Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci 119: 3981-3993.
35. Garcia EP, McPherson PS, Chilcote TJ, Takei K, De Camilli P, (1995) rbSec1A and B colocalize with Syntaxin 1 and SNAP-25 throughout the axon, but are not in a stable complex with syntaxin. J Cell Biol 129: 105-120.
36. Tao-Cheng JH, Du J, McBain CJ, (2000) Snap-25 is polarized to axons and abundant along the axolemma: an immunogold study of intact neurons. J Neurocytol 29: 67-77.
37. Welch MJ, Purkiss JR, Foster KA, (2000) Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38: 245-258.
38. Camprubí-Robles M, Planells-Cases R, Ferrer-Montiel A, (2009) Differential contribution of SNARE-dependent exocytosis to inflammatory potentiation of TRPV1 in nociceptors. FASEB J 23: 3722-3733.
39. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N, Ferrer-Montiel A, (2004) Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity. J Biol Chem 279: 25665-25672.
40. Kitamura Y, Matsuka Y, Spigelamn I, Ishihara Y, Yamamoto Y, et al. (2009) Botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction. Neuroscience 159: 1422-1429.
41. Xiao L, Cheng J, Dai J, Zhang D, (2011) Botulinum toxin decreases hyperalgesia and inhibits P2X3 receptor over-expression in sensory neurons induced by ventral root transection in rats. Pain Medicine12: 1385-1394.
42. Svensson CI, Brodin E, (2010) Spinal astocytes in pain processing. Mol Interv 10: 25-38.
43. Cobianchi S, Marinelli S, Florenzano F, Pavone F, Luvisetto S, (2010) Short- but not long-lasting treadmill running reduces allodynia and improves fucntional recovery after peripheral nerve injury. Neuroscience 168: 273-286.
44. Vacca V, Marinelli S, Eleuteri C, Luvisetto S, Pavone F, (2012) Botulinum neurotoxin A enhances the analgesic effects on inflammatory pain and antagonizes tolerance induced by morphine in mice. Brain Behav Immun 26: 489-499.
45. Volterra A and Meldolesi J (2005) Quantal release of transmitter: not only from neurons but from astrocytes as well? In: Neuroglia (Eds. Kettenmann H and Ransom BR), Oxford University Press, USA, 190-201.
46. Parpura V, Fang Y, Basarsky T, Jahn R, Haydon PG, (1995) Expression of synaptobrevin II, cellubrevin and syntaxin but not SNAP-25 in cultured astrocytes. FEBS Lett 377: 489-92.
47. Hepp R, Perraut M, Chasserot-Golaz S, Galli T, Aunis D, et al. (1999) Cultured glial cells express the SNAP-25 analogue SNAP-23. Glia 27: 181-187.
48. Jeftinija SD, Jeftinija KV, Stefanovic G, (1997) Cultured astrocytes express proteins involved in vesicular glutamate release. Brain Res 750: 41-47.
49. Schubert V, Bouvier D, Volterra A, (2011) SNARE protein expression in synaptic terminals and astrocytes in the adult hippocampus: a comparative analysis. Glia 59: 1472-1488.
50. Wilhelm A, Volknandt W, Langer D, Nolte C, Kettenmann H, et al. (2004) Localization of SNARE proteins and secretory organelle proteins in astrocytes in vitro and in situ. Neurosci Res 48: 249-257.
51. Maienschein V, Marxen M, Volknandt W, Zimmermann H, (1999) A plethora of presynaptic proteins associated with ATP-storing organelles in cultured astrocytes. Glia 26: 233-244.
52. Brookes JP, (1984) Assays for cholinergic properties in cultured rat Schwann cells. Proc R Soc Lond Biol Sci 222: 121-134.
53. Barden JA, Cotte LJ, Bennett MR, (1999) Vesicle-associated proteins and P2X receptor clusters at single sympathetic varoicosities in mouse vas deferens. J Neurocytol 28: 469-480.
54. Syed N, Reddy K, Yang DP, Taveggia C, Salzer JL, et al. (2010) Soluble Neuregulin 1 has bifunctional concentration dependent effects on Schwann cell myelination. J Neurosci 30: 6122-6131.
55. Zimmermann M, (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
56. Schiavo G, Montecucco C, (1995) Tetanus and botulism neurotoxins: isolation and assay. Meth Enzymol 248: 643-652.
57. Luvisetto S, Rossetto O, Montecucco C, Pavone F, (2003) Toxicity of botulinum neurotoxins in central nervous system in mice. Toxicon 4: 475-481.
58. Bennett GJ, Xie YK, (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
59. Brockes JP, (1987) Assay and isolation of glial growth factor from the bovine pituitary. Methods Enzimol 147: 217-225.
60. Davis JB, Stroobant P, (1990) Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells. J Cell Biol 110: 1353-1360.
61. Milara J, Serrano A, Peirò T, Amadeu G, Miralpeix M, et al. (2012) Aclidinium inhibits human lung fibroblast to myofibroblast transition. Thorax 97: 229-237.